Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes

Inflammatory breast carcinoma (IBC) is one of the most lethal forms of human breast cancer, and effective treatment for IBC is an unmet clinical need in contemporary oncology. Tumor-targeted theranostic approaches are emerging in precision medicine, but only a few specific biomarkers are available....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Proc Natl Acad Sci U S A
Egile Nagusiak: Dobroff, Andrey S., D’Angelo, Sara, Eckhardt, Bedrich L., Ferrara, Fortunato, Staquicini, Daniela I., Cardó-Vila, Marina, Staquicini, Fernanda I., Nunes, Diana N., Kim, Kisu, Driessen, Wouter H. P., Hajitou, Amin, Lomo, Lesley C., Barry, Marc, Krishnamurthy, Savitri, Sahin, Aysegul, Woodward, Wendy A., Prossnitz, Eric R., Anderson, Robin L., Dias-Neto, Emmanuel, Brown-Glaberman, Ursa A., Royce, Melanie E., Ueno, Naoto T., Cristofanilli, Massimo, Hortobagyi, Gabriel N., Marchiò, Serena, Gelovani, Juri G., Sidman, Richard L., Arap, Wadih, Pasqualini, Renata
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2016
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5111698/
https://ncbi.nlm.nih.gov/pubmed/27791177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1615288113
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak